Daniel Lorenzatti: EAT is not Just a Bystander but Also a Great Modifiable Therapeutic Target
Daniel Lorenzatti, Associate Research Scientist at Montefiore Health System and Cardiologist at Hospital Universitari de Vic, shared a post on LinkedIn about a recent article he and his colleagues co-authored:
“Excited to share our latest research published in JACC: Cardiovascular Imaging!
‘Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study’
From the PARADIGM (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging) registry – 773 patients using serial coronary CTA over a median 8-year follow-up.
- Higher EAT volume (EATv) is independently associated with CAD.
- EATv predicts both plaque progression (PP) and rapid plaque progression (RPP) – independent of traditional CV risk factors
- Noncalcified plaque showed nearly 7 times greater progression in the highest vs. lowest EATv tertile
- Patients with PP and RPP had significantly worse 10 – year MACE-free survival (log-rank P equales 0.003 and Pis is lower than 0.001)
EAT quantification – already obtainable from a standard coronary CTA acquisition – can refine risk stratification and identify patients who may benefit from earlier or more intensive preventive therapy.
EAT is not just a bystander; it may be a modifiable therapeutic target.
Proud to work alongside Annalisa Filtz under the guidance of Leandro Slipczuk in this multicenter effort.
Thanks to all the co – authors and specially to the Montefiore Health System incredible team!”
Title: Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study
Authors: Annalisa Filtz, Daniel Lorenzatti, Andrea Scotti, Kirtipal Bhatia, Felipe Contreras Yametti, Franco J. Cossettini, Hyuk-Jae Chang, Sang-Eun Lee, Piotr J. Slomka, Daniel S. Berman, Deepak L. Bhatt, Fay Y. Lin, Damini Dey, Leslee J. Shaw, Leandro Slipczuk
Read Full Article on JACC
Stay updated on Hemostasis Today.
-
May 10, 2026, 18:07Recurrent DVT and PE in Young Adults May Indicate an Underlying Cause – The Lancet Group
-
May 10, 2026, 18:06Noemi Zampatti: Pediatric Celiac Crisis Complicated by Refeeding Syndrome and Proposed Diagnostic Criteria
-
May 10, 2026, 18:05Giovanni Solimeno: When the Common Femoral Artery Wall is Diseased, Closure is Not a Step
-
May 10, 2026, 18:04Maitri Vaishnav: The Bombay Blood Group and the Critical Role of the H Antigen
-
May 10, 2026, 18:03Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
-
May 10, 2026, 16:20Joshua Ngimbwa: How Sex and Socioeconomic Factors Influence Stroke Outcomes in Tanzania
-
May 10, 2026, 16:18Gustavo Monnerat: How Thousands of Fake References Slipped Into Biomedical Literature
-
May 10, 2026, 16:13Dalius Jatužis: Our AI-Driven Automated Stroke Registry Data Extraction Gets Best Poster Award at ESOC 2026
-
May 10, 2026, 16:11Full House for Breakfast with the Experts – American Society for Apheresis